HMGB1 and Sepsis: A representative heptapeptide (VTK) was combined with the antibacterial peptide LL‐37, demonstrating bacteriostatic activity, inhibition of biofilm formation in vitro, reduced HMGB1 expression, and decreased vital organ injury in mice. Therefore, it is a good candidate for the treatment of sepsis.